Skip to content
Blogs
FEATURED | May 1, 2025

Why I’m Getting Naked for Skin Health 

Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...

3 Minute Read
Melanoma News |
March 18, 2022

FDA Grants Investigational New Drug Application fo...

On March 15, the U.S. Food and Drug Administration (FDA) granted Iovance Biotherapeutics, Inc. an Investigational New Drug Application (IND) for IOV-4001, its first geneti...

1 Minute Read
Blogs |
March 4, 2022

MRF Joins 100 Advocacy Organizations in Support of...

On February 25, 2022, the American Cancer Society Cancer Action Network (ACS-CAN) and the National Comprehensive Cancer Network (NCCN) sent a joint letter to the Majority a...

1 Minute Read
Blogs |
February 25, 2022

Rare Disease Day in the MRF Community

As the MRF observes Rare Disease Day on February 28, 2022, we celebrate the courageous and inspiring members of our community who are living with a rare melanoma subtype. M...

3 Minute Read
Blogs |
February 23, 2022

US Representative Carolyn Maloney to Headline MRF ...

WASHINGTON, DC (February 23, 2022) – The Melanoma Research Foundation (MRF) will host nearly 100 advocates during the all-virtual MRF Advocacy Days held March 7-11, 2022....

3 Minute Read
Blogs |
February 22, 2022

Out of the Shadows and “In the Sun”: Reflectio...

Guest blog post by Monique Mack, “In the Sun” documentary participant, melanoma survivor and MRF advocate:   My name is Monique Mack, and I am honored to be an advoca...

3 Minute Read
Blogs |
February 22, 2022

Bringing Awareness of Sun Safety and Sun Care to t...

Guest blog post by Katonya Breaux, Founder, Unsun Cosmetics and MRF advocate:   I discovered moles on my face that I thought were genetic, but after a visit to the dermato...

3 Minute Read
Blogs |
February 17, 2022

Hope in the Ocular Melanoma Journey

Guest blog post by Samantha Buirski, ocular melanoma patient, advocate and member of the CURE OM Patient Steering Committee: Being part of a rare community is challenging. ...

4 Minute Read
Melanoma News |
February 11, 2022

The First FDA Approved Treatment for Metastatic Uv...

On January 26, 2022, the U.S. Food and Drug Administration announced the approval of KIMMTRAK (tebentafusp-tebn), the first and only FDA-approved treatment for metastatic u...

2 Minute Read
Blogs |
February 11, 2022

Advocating Through Research Review Processes

Guest blog post by Kristin R. McJunkins, Stage III melanoma survivor and advocate: In 2008 when I was 38 years old, I was diagnosed with Stage IIIa cutaneous melanoma. Afte...

2 Minute Read
Melanoma News |
February 9, 2022

A Monumental First Step in Uveal Melanoma

Guest blog post by Keith T. Flaherty, MD, Associate Professor of Medicine at Harvard Medical School, Director of Developmental Therapeutics at Massachusetts General Hospita...

4 Minute Read
Blogs |
January 21, 2022

Scientific Peer Review of Congressionally Directed...

The MRF is proud to share the following press release from the Congressionally Directed Medical Research Program announcing MRF Board Chair (and melanoma survivor) Doug Bro...

2 Minute Read
Blogs |
December 22, 2021

25th Anniversary: A Mouse Model in BRAF-induced Me...

Guest blog post by Martin McMahon, PhD, Senior Director of Preclinical Research, Principal Investigator at Huntsman Cancer Institute. Dr. McMahon received the Diana Ashby S...

4 Minute Read

Jul 02, 2025 ET

Ask The Expert: ASCO 2025 Highlights: What Cutaneous Melanoma Patients Need to Know

Jul 15, 2025 ET

Ask The Expert: Focusing on the Liver: Treatment Approaches in Metastatic Uveal Melanoma

Jul 20, 2025 ET

Miles for Melanoma Chicago, IL

Jul 22, 2025 ET

Ask The Expert: 2025 ASCO Highlights for the Uveal Melanoma Community

Aug 03, 2025 ET

Miles for Melanoma Cleveland, OH

Aug 10, 2025 ET

Miles for Melanoma Twin Cities, MN

Aug 23, 2025 ET

Miles for Melanoma Philadelphia, PA

Explore Events